O-(2-MethoxyEthoxy)BenzeneSulfonamide

We are O-(2-MethoxyEthoxy)BenzeneSulfonamide CAS:93093-02-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 93093-02-9
Product Name: O-(2-MethoxyEthoxy)BenzeneSulfonamide
Other Name:
O-(2-MethoxyEthoxy)BenzeneSulfonamide
 
Molecular Formula: C9H13NO4S
Molecular Weight: 231.26882
 
Specification
Appearance: White solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Cinosulfuron CAS: 94593-91-6.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Cinosulfuron.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

O-(2-MethoxyEthoxy)BenzeneSulfonamide


Related News: Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.39895-55-1 Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.3-Fluoro-4-nitrobenzoic acid CAS:403-21-4 By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.3-Acetyl-5-chlorothiophene-2-sulfonamide Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).“Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.

Related Products
Product Name
2-Chloro-4-fluoroaniline View Details
1-Chloro-3-fluorobenzene View Details
2-((2-Nitro-4-(trifluoromethyl)phenyl)amino)ethanol View Details
3,5-Difluoroaniline manufacturer 2,4,6-Trimethylaniline manufacturer 2-((4-Cyanophenyl)amino)acetic acid manufacturer 6-Chloro-2-fluoropurine manufacturer N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide manufacturer